ENvue Medical Inc
FEED
6 hedge funds and large institutions have $163K invested in ENvue Medical Inc in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.08% less ownership
Funds ownership: 0.16% → 0.08% (-0.08%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less capital invested
Capital invested by funds: $327K → $163K (-$164K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.73K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$88.3K |
| 2 |
Renaissance Technologies
New York
|
-$13.4K |
| 3 |
AFS
Amtrust Financial Services
New York
|
-$11.2K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$14 |
| 5 |
Morgan Stanley
New York
|
-$9 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $95.8K | -$88.3K | -1,037 | -45% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $21.1K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $16.2K | +$6.73K | +79 | +60% |
|
|
4
Renaissance Technologies
New York
| $15.1K | -$13.4K | -157 | -44% |
|
|
5
Citadel Advisors
Miami,
Florida
| $10.8K | +$3.66K | +43 | +44% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4.25K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $32 | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $12 | – | – | – |
|
|
AFS
9
Amtrust Financial Services
New York
| – | -$11.2K | -113 | Closed |
|
|
10
Morgan Stanley
New York
| – | -$9 | – | – |
|
|
11
Wells Fargo
San Francisco,
California
| – | -$14 | – | – |
|
FEED Hedge Fund Activity: Q2 2024 in Review
6 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q2 2024, worth a combined $163K — down 50% from $327K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FEED and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $6.73K. The largest seller was Armistice Capital, cutting an estimated $88.3K.
- 6 institutional investors held ENvue Medical Inc (FEED) as of Q2 2024, down from 7 in Q1 2024.
- Funds reported $163K of ENvue Medical Inc stock for Q2 2024, down 50% quarter-over-quarter.
- 0 funds opened new ENvue Medical Inc positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest ENvue Medical Inc buyer in Q2 2024 was Geode Capital Management, an estimated $6.73K added.
- The largest ENvue Medical Inc seller in Q2 2024 was Armistice Capital, an estimated $88.3K sold.
Based on aggregated 13F filings for Q2 2024.